haloperidol has been researched along with ceruletide in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (68.57) | 18.7374 |
| 1990's | 11 (31.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibii, N; Ikeda, M; Kihara, T; Matsushita, A | 1 |
| Harro, J; Lang, A; Soosaar, A; Vasar, E | 1 |
| Hagino, Y; Moroji, T; Okuwa, M | 1 |
| Asami, T; Ida, I; Kuribara, H; Machiyama, Y; Tadokoro, S | 1 |
| Asami, T; Ida, I; Kuribara, H; Tadokoro, S | 1 |
| Allikmets, L; Lang, A; Soosaar, A; Vasar, E | 1 |
| Ikeda, M; Kihara, T; Matsushita, A | 1 |
| Kito, S; Shimoyama, M | 1 |
| Zetler, G | 8 |
| Mueller, K; Peel, JL; Rewey, KL | 1 |
| Matsubara, K; Matsushita, A | 4 |
| Allikmets, L; Maimets, M; Nurk, A; Soosaar, A; Vasar, E | 1 |
| Maeda, H; Maki, S; Uchimura, H | 1 |
| Allikmets, LKh; Soosaar, AKh; Vasar, EE | 1 |
| Allikmets, LKh; Prakh'e, IB; Ryzhov, IV; Soosaar, AKh; Vasar, EE | 1 |
| Hashimoto, M; Hirai, T; Oguchi, K; Yasuhara, H | 1 |
| Baumann, GH; Zetler, G | 1 |
| Allikmets, LKh; Maĭmets, MO; Soosaar, AKh; Vasar, EE | 1 |
| Aoki, N; Moroji, T; Tada, K; Watanabe, N | 1 |
| Allikmets, L; Maimets, M; Nurk, A; Vasar, E | 1 |
| Battaini, F; Faccini, E; Govoni, S; Locatelli, P; Pasinetti, G; Trabucchi, M | 1 |
| Kuribara, H | 1 |
| Hatta, S; Hatta, Y; Saito, T | 1 |
| Başar, E; Başar-Eroglu, C; Zetler, G | 1 |
| Feifel, D; Reza, T; Robeck, S | 1 |
35 other study(ies) available for haloperidol and ceruletide
| Article | Year |
|---|---|
Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
Topics: Animals; Benzodiazepinones; Ceruletide; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Male; Phenylurea Compounds; Potassium; Proglumide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Vagotomy | 1992 |
Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol.
Topics: Aggression; Animals; Behavior, Animal; Ceruletide; Dextroamphetamine; Diazepam; Electroshock; Haloperidol; Male; Mice; Motor Activity; Picrotoxin; Receptors, Cholecystokinin; Seizures | 1992 |
Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
Topics: Animals; Benzodiazepinones; beta-Endorphin; beta-Lipotropin; Brain; Bromocriptine; Ceruletide; Devazepide; Drug Interactions; Haloperidol; Hypothalamus; Kinetics; Male; Pituitary Gland; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |
[Characteristics of antagonism between ceruletide and various central-acting drugs: investigation by means of ambulatory activity in mice].
Topics: Animals; Bromocriptine; Caffeine; Ceruletide; Cocaine; Dose-Response Relationship, Drug; Drug Tolerance; Ephedrine; Haloperidol; Male; Methamphetamine; Methylphenidate; Mice; Morphine; Motor Activity; Scopolamine | 1990 |
Effects of ceruletide, administered singly and in combination with central-acting drugs, on discrete shuttle avoidance response in mice.
Topics: Animals; Avoidance Learning; Ceruletide; Chlorpromazine; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Mice; Phenylisopropyladenosine; Pilocarpine; Psychotropic Drugs | 1990 |
Similar behavioral and biochemical effects of long-term haloperidol and caerulein treatment in albino mice.
Topics: Amphetamine; Animals; Brain; Ceruletide; Drug Interactions; Exploratory Behavior; Flumazenil; Haloperidol; Male; Mice; Muscimol; Time Factors | 1990 |
Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ceruletide; Corpus Striatum; Dopamine; Haloperidol; Kinetics; Male; Perfusion; Potassium; Rats; Rats, Inbred Strains | 1990 |
Effect of cerulein on in vivo release of acetylcholine from the rat striatum.
Topics: Acetylcholine; Animals; Ceruletide; Cholinergic Fibers; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Potassium; Rats; Rats, Inbred Strains; Vagus Nerve | 1989 |
Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ceruletide; Dose-Response Relationship, Drug; Haloperidol; Humans; Irritants; Male; Mice; Scopolamine; Sincalide; Stereotyped Behavior; Thioxanthenes; Trifluoperazine | 1985 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Effects of caerulein + haloperidol on amphetamine-induced locomotor stereotypy in rats.
Topics: Amphetamine; Animals; Ceruletide; Drug Interactions; Haloperidol; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1989 |
Study on the mechanism of the long-lasting antagonistic effect of caerulein on amphetamine-induced hyperactivity in rats.
Topics: Amphetamine; Animals; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Ceruletide; Endorphins; Haloperidol; Hydroxydopamines; Male; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium Glutamate | 1986 |
Comparison of motor depressant effects of caerulein and N-propylnorapomorphine in mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Apomorphine; Ceruletide; Depression, Chemical; Exploratory Behavior; Fenclonine; Haloperidol; Hydroxydopamines; Male; Mice; Motor Activity; Nerve Endings; Oxidopamine; Receptors, Dopamine; Receptors, Serotonin; Sincalide; Spiperone | 1986 |
beta-Endorphin involvement in the antidopaminergic effect of caerulein.
Topics: Amphetamine; Animals; beta-Endorphin; Ceruletide; Endorphins; Haloperidol; Hypophysectomy; Injections, Intraventricular; Male; Motor Activity; Naloxone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide | 1986 |
Facilitatory effects of caerulein on hypothalamic defensive attack in cats.
Topics: Aggression; Agonistic Behavior; Animals; Behavior, Animal; Cats; Ceruletide; Dose-Response Relationship, Drug; Electric Stimulation; Haloperidol; Hypothalamus; Injections, Intraventricular | 1988 |
[Antagonism of caerulein, a CCK-8 receptor agonist, to the behavioral effects of ketamine in mice and rats].
Topics: Amnesia; Animals; Ataxia; Behavior, Animal; Ceruletide; Haloperidol; Ketamine; Male; Mice; Motor Activity; Naloxone; Rats; Receptors, Cholecystokinin; Stereotyped Behavior | 1988 |
[Species differences in the behavioral effects of cerulein--an agonist of the receptors of the octapeptide cholecystokinin--in white mice and rats].
Topics: Amphetamine; Animals; Behavior, Animal; Ceruletide; Drug Interactions; Haloperidol; Male; Mice; Motor Activity; Rats; Receptors, Cholecystokinin; Seizures; Species Specificity; Time Factors | 1988 |
Effect of caerulein with haloperidol on monoamine contents in rat brain regions treated with methamphetamine.
Topics: Animals; Brain; Ceruletide; Dopamine; Drug Interactions; Haloperidol; Male; Methamphetamine; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Tissue Distribution | 1986 |
The cholecystokinin-like peptide, ceruletide, reduces isolation-induced aggression in mice.
Topics: Aggression; Animals; Ceruletide; Depression, Chemical; Diazepam; Haloperidol; Male; Mice; Social Isolation | 1986 |
[Decreased sensitivity of cholecystokinin receptors in the brain as affected by the prolonged administration of haloperidol].
Topics: Animals; Brain; Ceruletide; Haloperidol; Male; Mice; Receptors, Cholecystokinin; Time Factors | 1986 |
Analysis of the long-lasting antagonistic effect of caerulein on amphetamine hyperactivity in rats.
Topics: Amphetamine; Animals; Apomorphine; Ceruletide; Haloperidol; Male; Motor Activity; Nomifensine; Rats; Rats, Inbred Strains; Time Factors; Tranylcypromine | 1985 |
Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
Topics: Animals; Apomorphine; Blepharoptosis; Catalepsy; Ceruletide; Clonidine; Drug Antagonism; Haloperidol; Humans; Hypnotics and Sedatives; Male; Mice; Motor Activity; Sincalide; Yohimbine | 1984 |
Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Body Temperature; Ceruletide; Clonazepam; Drug Antagonism; Haloperidol; Male; Methylphenidate; Mice; Peptide Fragments; Picrotoxin; Sincalide | 1983 |
A therapeutic trial of caerulein to a long-term heavy marihuana user with amotivational syndrome.
Topics: Adult; Brief Psychiatric Rating Scale; Ceruletide; Drug Therapy, Combination; Haloperidol; Humans; Male; Marijuana Abuse; Motivation; Nitrazepam; Promethazine; Syndrome | 1984 |
Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
Topics: Animals; Anticonvulsants; Ceruletide; Cholecystokinin; Diazepam; Haloperidol; Harmine; Isoniazid; Male; Mice; Mice, Inbred Strains; Seizures; Semicarbazides; Sincalide | 1981 |
Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
Topics: Animals; Anticonvulsants; Catalepsy; Central Nervous System Depressants; Ceruletide; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Receptors, Dopamine; Sincalide; Sleep; Stereotyped Behavior | 1981 |
Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
Topics: Animals; Body Temperature Regulation; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Morphine; Peptide Fragments; Sincalide; Time Factors | 1982 |
Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration.
Topics: Animals; Binding Sites; Butyrophenones; Ceruletide; Haloperidol; Male; Mice; Receptors, Dopamine; Receptors, Serotonin; Spiperone | 1984 |
Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ceruletide; Cholecystokinin; Corpus Striatum; Dopamine; Haloperidol; Male; Metabolism; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1984 |
Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol.
Topics: Amphetamine; Animals; Ceruletide; Haloperidol; Male; Motor Activity; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol.
Topics: Animals; Catalepsy; Ceruletide; Drug Interactions; Haloperidol; Humans; Male; Methylphenidate; Mice; Naloxone; Stereotyped Behavior | 1981 |
Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
Topics: Animals; Behavior, Animal; Ceruletide; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Time Factors | 1995 |
Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Ceruletide; Frontal Lobe; Guanylyl Imidodiphosphate; Haloperidol; Male; Neostriatum; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone | 1993 |
Effects of ceruletide and haloperidol on auditory evoked potentials in the cat brain.
Topics: Animals; Brain; Cats; Ceruletide; Dopamine Antagonists; Electrodes, Implanted; Electroencephalography; Evoked Potentials, Auditory; Female; Haloperidol; Neostigmine; Parasympathomimetics | 1996 |
Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Ceruletide; Cholecystokinin; Gastrointestinal Agents; Haloperidol; Injections, Subcutaneous; Male; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reflex, Startle; Tetragastrin | 1999 |